Abstract
AbstractBackgroundPsoriasis is a chronic skin inflammatory disease characterized by epidermal proliferation and inflammatory cell infiltration. AXL is a tyrosine kinase receptor that promotes cell proliferation and invasion in cancer cells, and its expression is elevated in multiple tumors. However, less is known about its expression and function in inflammatory diseases.ObjectivesThe aim of this study is to examine AXL expression in psoriasis and investigate the biological function of AXL under psoriatic conditions.ResultsAXL mRNA expression was decreased in psoriatic skin compared to healthy skin, and an inverse correlation with neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio was observed. Immunohistochemical staining of psoriatic skin revealed decreased AXL expression of the epidermis and an increased number of AXL‐positive dendritic cells in the dermis. Stimulation of epidermal keratinocytes with antimicrobial peptide LL37, but not with IL‐17A, resulted in decreased AXL expression. Knockdown of AXL in epidermal keratinocytes did not affect cell proliferation or expression of psoriasis‐associated cytokines and chemokines.ConclusionDecreased epidermal AXL expression and increased infiltration of AXL‐expressing dendritic cells were revealed in psoriasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
